ストックスクリーナーアプリを入手
32.53
1.48%
-0.49
アフターアワーズ：
32.03
-0.50
-1.54%
Alkermes Plc (ALKS) 最新ニュース
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia - Sharecast News
Alkermes Announces Initiation Of Vibrance-3 Phase 2 Study Evaluating Alks 2680 For The Treatment Of Idiopathic Hypersomnia - MarketScreener
(ALKS) Trading Report - news.stocktradersdaily.com
Deutsche Bank Adjusts Alkermes Public Price Target to $52 From $40, Maintains Buy Rating - MarketScreener
What 5 Analyst Ratings Have To Say About Alkermes - Benzinga
New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder - PR Newswire
Cibc World Markets Corp Buys New Shares in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition? - MSN
Mural Oncology stock plunges on trial halt (MURA:NASDAQ) - Seeking Alpha
Liposomal Drug Delivery Market Detailed In New Research Report - openPR.com
First Week of November 21st Options Trading For Alkermes (ALKS) - Nasdaq
Controlled Release Drug Delivery Market to Witness Massive - openPR.com
Alkermes price target raised to $35 from $34 at BofA - MSN
Where are the Opportunities in (ALKS) - news.stocktradersdaily.com
Insider Sale at Alkermes PLC: EVP R&D, Chief Medical Officer Cra - GuruFocus.com
Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report? - Yahoo Finance
Is Alkermes plc (ALKS) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey
Alkermes PLC Reports Q4 Revenue of $430 Million, Beating Estimat - GuruFocus.com
Alkermes' (NASDAQ:ALKS) investors will be pleased with their splendid 140% return over the last five years - Yahoo Finance
Alkermes (NASDAQ:ALKS) shareholders have earned a 19% CAGR over the last five years - Simply Wall St
Alkermes Facing Near-Term Headwinds Across Existing Franchises, Royalties, RBC Says - Marketscreener.com
RBC Capital Initiates Coverage of Alkermes (ALKS) with Sector Perform Recommendation - Nasdaq
S&P 500 Futures Drop in Premarket Trading; Alkermes, Intel Lead - Barron's
Alkermes initiated with a Sector Perform at RBC Capital - TipRanks
Charles Schwab Investment Management Inc. Sells 38,088 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Alkermes at Leerink’s Global Healthcare Conference: Strategic Pipeline Insights - Investing.com India
Alkermes at Leerink’s Global Healthcare Conference: Strategic Pipeline Insights By Investing.com - Investing.com South Africa
Alkermes to Participate in Upcoming Investor Conferences - GuruFocus.com
Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones - The Manila Times
Alkermes Plc to Host Earnings Call - ACCESS Newswire
Alkermes plc (NASDAQ:ALKS) Shares Bought by Smartleaf Asset Management LLC - Defense World
Proficio Capital Partners LLC Buys New Stake in Alkermes plc (NASDAQ:ALKS) - Defense World
(ALKS) Technical Pivots with Risk Controls - news.stocktradersdaily.com
What is Zacks Research’s Estimate for Alkermes Q1 Earnings? - Defense World
Zacks Research Predicts Alkermes FY2027 Earnings - Defense World
UBS Group Upgrades Alkermes (NASDAQ:ALKS) to Neutral - MarketBeat
Y Intercept Hong Kong Ltd Invests $413,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat
UBS Upgrades Alkermes (ALKS) - Nasdaq
Bank of New York Mellon Corp Has $61.45 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Alkermes (NASDAQ:ALKS) Upgraded to Neutral at UBS Group - Defense World
UBS Upgrades Alkermes to Neutral From Sell, $38 Price Target -March 04, 2025 at 08:27 am EST - Marketscreener.com
Alkermes upgraded to Neutral from Sell at UBS - TipRanks
Alkermes plc (ALKS): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
New York State Common Retirement Fund Increases Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Ieq Capital LLC Acquires New Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes VP Samuel Parisi sells $65,892 in shares - Investing.com India
Alkermes VP Samuel Parisi sells $65,892 in shares By Investing.com - Investing.com UK
Illinois Municipal Retirement Fund Sells 11,878 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) is HealthInvest Partners AB's 10th Largest Position - MarketBeat
C WorldWide Group Holding A S Purchases Shares of 250,000 Alkermes plc (NASDAQ:ALKS) - MarketBeat
Todd Asset Management LLC Sells 30,957 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Sanctuary Advisors LLC Acquires 1,917 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire
Blue Trust Inc. Purchases 1,629 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Alkermes VP of finance Samuel Joseph Parisi sells shares worth $131,978 By Investing.com - Investing.com South Africa
Alkermes VP of finance Samuel Joseph Parisi sells shares worth $131,978 - Investing.com India
0.34%
1.26%
大文字化:
|
ボリューム (24 時間):